Transient rapamycin treatment avoids unwanted host immune responses toward AAV-delivered anti-HIV antibodies

Journal:

Nature Communications

Published:

2025-10-07

DOI:

10.1038/s41467-025-63970-6

Affiliations:

4

Authors:

17

Go to article

Institutions	Authors	Share
University of Miami (UM), United States of America (USA)	6.000000	0.35
University of Wisconsin-Madison (UW-Madison), United States of America (USA)	5.000000	0.29
University of California, Los Angeles (UCLA), United States of America (USA)	4.000000	0.24
University of Massachusetts Chan Medical School (UMass Chan Medical School), United States of America (USA)	2.000000	0.12

Interested in Clinical Sciences?